Krish Krishnan: Engineering Hope for Rare Disease Patients
Discover how Krish Krishnan transformed Krystal Biotech into a multi-billion-dollar gene therapy pioneer, leading the launch of VYJUVEK® and redefining rare disease treatment…
Read More...
Read More...